Politics
Cancer-Drug Legislation Would Reduce Costs for Thousands of Patients
Around the State

Sen. Lizbeth Benacquisto | Credit: Dave Heller
The troubling truth is that cancer drugs can cost more, depending on how they’re administered.
That’s patently unfair, according to a couple of state lawmakers who want to put an end to huge differences in prices for drugs taken orally and intravenously. They are championing the Cancer Treatment Fairness Act, SB 422 in the Senate and HB 301 in the House.
Sen. Lizbeth Benacquisto, R-Fort Myers, and Rep. Debbie Mayfield, R-Vero Beach, say cancer patients typically pay a $30 co-pay for IV cancer medications. But the cost for the same oral drug might cost thousands of dollars a month.
Sometimes the IV version is not available. That happened to Luke Webb, faced with a $7,000 monthly bill for oral chemotherapy.
He is pleading with lawmakers to pass the bill that would require insurers to offer their IV and oral cancer treatments at the same price. See the video clip below.
“Please don’t restrict access to these medications. Please treat them the same as IV medications and it’s patients like me who are calling on those in the state of Florida with power, those standing around me, to do what they can. They have the power to make the changes, to change these policies and to remember patients are counting them.”
“We will take nothing but yes for an answer to make sure that we provide an opportunity for folks to do what they need to do without worrying that they cannot afford the medication that they so desperately need to save their lives.”
The legislation would not tell insurers to offer new cancer coverage, but would require them not to charge more for oral treatments.
Sorry, you need to install flash to see this content.
Video Credit: Dave Heller
Dave Heller is a Tallahassee freelance reporter/videographer.

Comments (3)
Thank you for speaking up for so many of us.
You are a wonderful roll model.
It only takes a minute to sign on and it would allow "any patient diagnosed with a terminal illness, for whom a physician determines that FDA-approved drugs are likely not curative, may obtain access to any experimental drug upon execution of an informed consent without the need for FDA approval."
*Since I can't leave a link without being confused with a spammer, copy and paste the following into Google and you'll see the link.
Alliance for Natural Health + Tell Congress to support the Compassionate Care Act
Leave a Comment on This Story